AZD-8165

DB15132InvestigationalSmall molecule

AZD-8165 is under investigation in clinical trial NCT01150812 (Oral AZD8165 After Single Oral Ascending Doses in Healthy Male Subjects).

Chemical structure of AZD-8165
Formula / weight
C23H21ClFN7O4 · 513.91 g/mol (avg)
Code names
AZD-8165

Resolves to

Compound
UNII7WO8I5IY24CAS1201686-72-7ChEMBLCHEMBL3786896
Structure
InChIKeyYUHNXUAATAMVKD-PZJWPPBQSA-NSMILESCCC(=O)O[C@@H](C(=O)N1N=CC[C@H]1C(=O)NCC1=C(C=CC(Cl)=C1)N1C=NN=N1)C1=CC=C(F)C=C1
Targets
P00734F2

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with AZD-8165, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In